GlobalDatas new report, Drug Delivery Devices Market Outlook in Netherlands to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections provides key market data on the Netherlands Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within four market categories Central Venous Catheters, Infusion Systems, Metered Dose Inhaler Devices and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

• Market size and company share data for Drug Delivery Devices market categories Central Venous Catheters, Infusion Systems, Metered Dose Inhaler Devices and Needle Free Injections.
• Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within four market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017. 
• 2010 company shares and distribution shares data for each of the four market categories.
• Global corporate-level profiles of key companies operating within the Netherlands Drug Delivery Devices market. 
• Key players covered include GlaxoSmithKline plc, Boehringer Ingelheim GmbH, AstraZeneca PLC, Baxter International Inc., CareFusion Corporation, Sunovion and others.

Reasons to buy

• Develop business strategies by identifying the key market categories and segments poised for strong growth.
• Develop market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the Netherlands Drug Delivery Devices competitive landscape.
• Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
• What are the key distribution channels and whats the most preferred mode of product distribution Identify, understand and capitalize.

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 9

List of Tables

Table 1: Drug Delivery Devices, Netherlands, Overall Revenue ($m), 2003-2017 14
Table 2: Drug Delivery Devices Market, Netherlands, Category Contribution (%), 2010 16
Table 3: Drug Delivery Devices, Netherlands Cross-Category Analysis, 2003-2017 17
Table 4: Drug Delivery Devices, Netherlands, Overall Revenue ($m), Historic, 2003-2010 19
Table 5: Drug Delivery Devices, Netherlands, Overall Revenue ($m), Forecast, 2010-2017 21
Table 6: Drug Delivery Devices, Netherlands, Category Volume (Units), 2003-2017 22
Table 7: Drug Delivery Devices, Netherlands, Category Volume (Units), Historic, 2003-2010 24
Table 8: Drug Delivery Devices, Netherlands, Category Volume (Units), Forecast, 2010-2017 26
Table 9: Drug Delivery Devices, Netherlands, Company Share by Revenue ($m), 2009-2010 28
Table 10: Central Venous Catheters Market, Netherlands, Segment Contribution (%), 2010 31
Table 11: Central Venous Catheters, Netherlands, Revenue ($m) by Segment, Historic, 2003-2010 33
Table 12: Central Venous Catheters, Netherlands, Revenue ($m) by Segment, Forecast, 2010-2017 35
Table 13: Central Venous Catheters, Netherlands, Volume (Units) by Segment, Historic, 2003-2010 37
Table 14: Central Venous Catheters, Netherlands, Volume (Units) by Segment, Forecast, 2010-2017 39
Table 15: Central Venous Catheters, Netherlands, Average Price ($), Historic, 2003-2010 40
Table 16: Central Venous Catheters, Netherlands, Average Price ($), Forecast, 2010-2017 40
Table 17: Central Venous Catheters, Netherlands, Distribution Share by Revenue ($m), 2009-2010 41
Table 18: Central Venous Catheters, Netherlands, Company Share by Revenue ($m), 2009-2010 43
Table 19: Infusion Systems Market, Netherlands, Segment Contribution (%), 2010 46
Table 20: Infusion Systems, Netherlands, Revenue ($m) by Segment, Historic, 2003-2010 48
Table 21: Infusion Systems, Netherlands, Revenue ($m) by Segment, Forecast, 2010-2017 50
Table 22: Syringe Pumps, Netherlands, Revenue ($m) by Sub-Segment, Historic, 2003-2010 52
Table 23: Syringe Pumps, Netherlands, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 54
Table 24: Ambulatory Infusion Pumps, Netherlands, Revenue ($m) by Sub-Segment, Historic, 2003-2010 56
Table 25: Ambulatory Infusion Pumps, Netherlands, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 58
Table 26: Infusion Systems, Netherlands, Volume (Units) by Segment, Historic, 2003-2010 60
Table 27: Infusion Systems, Netherlands, Volume (Units) by Segment, Forecast, 2010-2017 62
Table 28: Syringe Pumps, Netherlands, Volume (Units) by Sub-Segment, Historic, 2003-2010 64
Table 29: Syringe Pumps, Netherlands, Volume (Units) by Sub-Segment, Forecast, 2010-2017 65
Table 30: Ambulatory Infusion Pumps, Netherlands, Volume (Units) by Sub-Segment, Historic, 2003-2010 67
Table 31: Ambulatory Infusion Pumps, Netherlands, Volume (Units) by Sub-Segment, Forecast, 2010-2017 69
Table 32: Infusion Systems, Netherlands, Average Price ($), Historic, 2003-2010 70
Table 33: Infusion Systems, Netherlands, Average Price ($), Forecast, 2010-2017 70
Table 34: Infusion Systems, Netherlands, Distribution Share by Revenue ($m), 2009-2010 71
Table 35: Infusion Systems, Netherlands, Company Share by Revenue ($m), 2009-2010 73
Table 36: Metered Dose Inhaler Devices, Netherlands, Revenue ($m), Historic, 2003-2010 75
Table 37: Metered Dose Inhaler Devices, Netherlands, Revenue ($m), Forecast, 2010-2017 76
Table 38: Metered Dose Inhaler Devices, Netherlands, Volume (Units), Historic, 2003-2010 77
Table 39: Metered Dose Inhaler Devices, Netherlands, Volume (Units), Forecast, 2010-2017 78
Table 40: Metered Dose Inhaler Devices, Netherlands, Average Price ($), Historic, 2003-2010 79
Table 41: Metered Dose Inhaler Devices, Netherlands, Average Price ($), Forecast, 2010-2017 79
Table 42: Metered Dose Inhaler Devices, Netherlands, Distribution Share by Revenue ($m), 2009-2010 80
Table 43: Metered Dose Inhaler Devices, Netherlands, Company Share by Revenue ($m), 2009-2010 82
Table 44: Needle Free Injections, Netherlands, Revenue ($m), Historic, 2003-2010 83
Table 45: Needle Free Injections, Netherlands, Revenue ($m), Forecast, 2010-2017 84
Table 46: Needle Free Injections, Netherlands, Volume (Units), Historic, 2003-2010 85
Table 47: Needle Free Injections, Netherlands, Volume (Units), Forecast, 2010-2017 86
Table 48: Needle Free Injections, Netherlands, Average Price ($), Historic, 2003-2010 87
Table 49: Needle Free Injections, Netherlands, Average Price ($), Forecast, 2010-2017 87
Table 50: Needle Free Injections, Netherlands, Distribution Share by Revenue ($m), 2009-2010 88
Table 51: Needle Free Injections, Netherlands, Company Share by Revenue ($m), 2009-2010 90
Table 52: Drug Delivery Devices Market Pipeline Products 104
Table 53: USD to Local Currency, Netherlands, Average Actual Rate 2003-2010 115

List of Figures

Figure 1: Drug Delivery Devices, Market Segmentation 12
Figure 2: Drug Delivery Devices, Netherlands, Overall Revenue ($m), 2003-2017 13
Figure 3: Drug Delivery Devices Market, Netherlands, Revenue Mix ($m), 2010 15
Figure 4: Drug Delivery Devices Market, Netherlands, Category Contribution (%), 2010 16
Figure 5: Drug Delivery Devices Market, Netherlands, Cross-Category Analysis, 2003-2017 17
Figure 6: Drug Delivery Devices, Netherlands, Overall Revenue ($m), Historic, 2003-2010 18
Figure 7: Drug Delivery Devices, Netherlands, Overall Revenue ($m), Forecast, 2010-2017 20
Figure 8: Drug Delivery Devices, Netherlands, Category Volume (Units), 2003-2017 22
Figure 9: Drug Delivery Devices, Netherlands, Category Volume (Units), Historic, 2003-2010 23
Figure 10: Drug Delivery Devices, Netherlands, Category Volume (Units), Forecast, 2010-2017 25
Figure 11: Drug Delivery Devices, Netherlands, Company Share (%), 2010 27
Figure 12: Central Venous Catheters, Market Segmentation 29
Figure 13: Central Venous Catheters Market, Netherlands, Revenue Mix ($m), 2010 30
Figure 14: Central Venous Catheters Market, Netherlands, Segment Contribution (%), 2010 31
Figure 15: Central Venous Catheters, Netherlands, Revenue ($m) by Segment, Historic, 2003-2010 32
Figure 16: Central Venous Catheters, Netherlands, Revenue ($m) by Segment, Forecast, 2010-2017 34
Figure 17: Central Venous Catheters, Netherlands, Volume (Units) by Segment, Historic, 2003-2010 36
Figure 18: Central Venous Catheters, Netherlands, Volume (Units) by Segment, Forecast, 2010-2017 38
Figure 19: Central Venous Catheters, Netherlands, Company Share (%), 2010 42
Figure 20: Infusion Systems, Market Segmentation 44
Figure 21: Infusion Systems Market, Netherlands, Revenue Mix ($m), 2010 45
Figure 22: Infusion Systems Market, Netherlands, Segment Contribution (%), 2010 46
Figure 23: Infusion Systems, Netherlands, Revenue ($m) by Segment, Historic, 2003-2010 47
Figure 24: Infusion Systems, Netherlands, Revenue ($m) by Segment, Forecast, 2010-2017 49
Figure 25: Syringe Pumps, Netherlands, Revenue ($m) by Sub-Segment, Historic, 2003-2010 51
Figure 26: Syringe Pumps, Netherlands, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 53
Figure 27: Ambulatory Infusion Pumps, Netherlands, Revenue ($m) by Sub-Segment, Historic, 2003-2010 55
Figure 28: Ambulatory Infusion Pumps, Netherlands, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 57
Figure 29: Infusion Systems, Netherlands, Volume (Units) by Segment, Historic, 2003-2010 59
Figure 30: Infusion Systems, Netherlands, Volume (Units) by Segment, Forecast, 2010-2017 61
Figure 31: Syringe Pumps, Netherlands, Volume (Units) by Sub-Segment, Historic, 2003-2010 63
Figure 32: Syringe Pumps, Netherlands, Volume (Units) by Sub-Segment, Forecast, 2010-2017 65
Figure 33: Ambulatory Infusion Pumps, Netherlands, Volume (Units) by Sub-Segment, Historic, 2003-2010 66
Figure 34: Ambulatory Infusion Pumps, Netherlands, Volume (Units) by Sub-Segment, Forecast, 2010-2017 68
Figure 35: Infusion Systems, Netherlands, Company Share (%), 2010 72
Figure 36: Metered Dose Inhaler Devices, Netherlands, Revenue ($m), Historic, 2003-2010 74
Figure 37: Metered Dose Inhaler Devices, Netherlands, Revenue ($m), Forecast, 2010-2017 76
Figure 38: Metered Dose Inhaler Devices, Netherlands, Volume (Units), Historic, 2003-2010 77
Figure 39: Metered Dose Inhaler Devices, Netherlands, Volume (Units), Forecast, 2010-2017 78
Figure 40: Metered Dose Inhaler Devices, Netherlands, Company Share (%), 2010 81
Figure 41: Needle Free Injections, Netherlands, Revenue ($m), Historic, 2003-2010 83
Figure 42: Needle Free Injections, Netherlands, Revenue ($m), Forecast, 2010-2017 84
Figure 43: Needle Free Injections, Netherlands, Volume (Units), Historic, 2003-2010 85
Figure 44: Needle Free Injections, Netherlands, Volume (Units), Forecast, 2010-2017 86
Figure 45: Needle Free Injections, Netherlands, Company Share (%), 2010 89
Figure 46: GlaxoSmithKline plc, Company Share (%),Netherlands Drug Delivery Devices Market, 2010 91
Figure 47: Boehringer Ingelheim GmbH, Company Share (%),Netherlands Drug Delivery Devices Market, 2010 92
Figure 48: AstraZeneca PLC, Company Share (%),Netherlands Drug Delivery Devices Market, 2010 93
Figure 49: Baxter International Inc., Company Share (%),Netherlands Drug Delivery Devices Market, 2010 94
Figure 50: CareFusion Corporation, Company Share (%),Netherlands Drug Delivery Devices Market, 2010 95
Figure 51: Sunovion, Company Share (%),Netherlands Drug Delivery Devices Market, 2010 96